• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

  2. What the Heck Is Robotic Surgery?

    Morningstar OptionInvestor editor Erik Kobayashi-Solomon and senior health-care analyst Julie Stralow discuss Intuitive Surgical's appeal and outlook.

  3. Marcus: A Perfect Time for Deep-Value Investors

    Evermore's David Marcus, formerly of Mutual Series, says companies are using the European crisis to transform their businesses even faster to gear for the next phase of growth.

  4. Personalized Medicine is the Future

    Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.

  1. Siemens AG SI Q3 2011 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to Siemens 2011 Third Quarter Conference Call. As a reminder, this conference is being recorded. Before we begin, I would like to draw your attention to the Safe Harbor statements on Page 2 of the Siemens presentation.

  2. Siemens AG SI Q2 2011 Earnings Call Transcript

    Good morning, ladies and gentlemen, and welcome to Siemens Second Quarter Fiscal 2011 Conference Call.

  3. Siemens AG SI Q4 2011 Earnings Call Transcript

    Good afternoon, ladies and gentlemen, and welcome to Siemens 2011 Fourth Quarter Conference Call.

  4. Beckman Coulter, Inc. BEC Q1 2010 Earnings Call Transcript

    Good afternoon. My name is Marcello and I ll be your conference operator today. At this time, I would like to welcome everyone to the Beckman Coulter Q1 Earnings Release Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.